Transplantation Archives

Transplantation

Caring for patients with solid organ transplants

September 10, 2015

Donald Brooks, age 57, comes to the emergency department after fracturing his right hip in a skiing accident. He is admitted to the orthopedic progressive care unit for…

FDA approves DNA test to help manage CMV infection in organ transplant patients

June 11, 2012

On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps gauge the progress of anti-viral treatment…

FDA approves Liposorber Apheresis System for pediatric use

October 11, 2013

On Oct. 10, the U.S. Food and Drug Administration (FDA) approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS) either before transplant, or…

FDA approves Nulojix for prevention of acute rejection in kidney transplant patients

June 11, 2011

The U.S. Food and Drug Administration (FDA) has approved Nulojix (belatacept) for prevention of acute rejection in adult patients who have had a kidney transplant. Read more.

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

June 11, 2013

The author describes an innovative technique that is helping patients with C. difficile infection, including patient selection; care before, during, and after the procedure; and patient education.

MARS®: The new frontier in treating acute liver failure

March 11, 2014

A type of dialysis, MARS removes toxins and replaces lost liver functions.

Maximizing organ donation through aggressive donor management

February 11, 2011

Currently, more than 110,000 Americans are on the waiting list for a life-saving organ transplant. Each year, more than 5,000 people die while still waiting. Between January and…

More than half of liver transplant recipients develop metabolic syndrome

December 11, 2010

According to a study in January’s Liver Transplantation, more than half (52%) of liver transplant recipients develop metabolic syndrome. Read more at http://onlinelibrary.wiley.com/doi/10.1002/lt.22198/abstract.

New policies for evaluating living kidney donors approved by OPTN/UNOS

November 11, 2012

The OPTN/UNOS Board of Directors has approved policies aimed at creating greater consistency in the medical and psychosocial evaluation and informed consent processes for living kidney donors and…

Nurturing the tree of life

November 11, 2009

In the United States, more than 15,000 families a year make the difficult decision to donate their loved ones’ organs. One day in August 2005, two of these…

Study: Fecal microbiota transplant effective in immunocompromised patients

July 28, 2014

Fecal microbiota transplant (FMT) for the treatment of Clostridium difficile infection in immunocompromised patients is safe and effective, according to a study in the American Journal of Gastroenterology.…

Study: Kidney transplant patients prone to early readmission

October 11, 2012

According to a study in the American Journal of Transplantation, 31% of kidney transplant patients are readmitted to the hospital within 30 days of discharge. Factors increasing the…

Through the kindness of strangers

April 11, 2013

Our editor-in-chief shares her the impact of a tendon transplant on her life and discusses the importance of organ and tissue donation.

Caring for patients with solid organ transplants

Donald Brooks, age 57, comes to the emergency department after fracturing his right hip in a skiing accident. He is admitted to the orthopedic…

FDA approves DNA test to help manage CMV infection in organ transplant patients

On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps gauge the…

FDA approves Liposorber Apheresis System for pediatric use

On Oct. 10, the U.S. Food and Drug Administration (FDA) approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS)…

FDA approves Nulojix for prevention of acute rejection in kidney transplant patients

The U.S. Food and Drug Administration (FDA) has approved Nulojix (belatacept) for prevention of acute rejection in adult patients who have had a kidney…

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

The author describes an innovative technique that is helping patients with C. difficile infection, including patient selection; care before, during, and after the procedure;…

MARS®: The new frontier in treating acute liver failure

A type of dialysis, MARS removes toxins and replaces lost liver functions.

Maximizing organ donation through aggressive donor management

Currently, more than 110,000 Americans are on the waiting list for a life-saving organ transplant. Each year, more than 5,000 people die while still…

More than half of liver transplant recipients develop metabolic syndrome

New policies for evaluating living kidney donors approved by OPTN/UNOS

The OPTN/UNOS Board of Directors has approved policies aimed at creating greater consistency in the medical and psychosocial evaluation and informed consent processes for…

Nurturing the tree of life

In the United States, more than 15,000 families a year make the difficult decision to donate their loved ones’ organs. One day in August…

Study: Fecal microbiota transplant effective in immunocompromised patients

Fecal microbiota transplant (FMT) for the treatment of Clostridium difficile infection in immunocompromised patients is safe and effective, according to a study in the…